NCT00135109View on ClinicalTrials.gov

Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

654

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Diabetic Neuropathies
Interventions
DRUG

SPM 927

Trial Locations (1)

27709

Schwarz, RTP

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY